CBD oil is a hemp extract rich in cannabidiol, diluted in a carrier oil - most often MCT, hemp or olive oil. As of September 2026, this format is not authorized for sale in France as a food product, whatever its concentration or the origin of the extract. WorldWeed doesn't offer it, for this precise reason: the shop is limited to CBD flowers and resins.
This isn't a matter of trend or business choice. It's a clear-cut regulatory issue, restated by the Ministry of Agriculture on 20 May 2026: any food product containing CBD added to its ingredients, oils and supplements included, must be withdrawn from the market.
If you were looking for a CBD oil to try the product, this guide explains why you won't find one for legal sale anymore, what remains authorized instead, and what you were risking with the oils sold until now without a harmonized control framework.
Key points — CBD oils (extract + carrier oil) fall under the European "novel food" regulation: EFSA hasn't been able to validate their safety, for lack of sufficient data. The Ministry of Agriculture restated on 20 May 2026 that these food products, food supplements included, aren't authorized for sale and must be withdrawn from the market. Hemp seed oil (with no CBD) and leaves for unenriched aqueous infusion remain exempt. A 2017 JAMA study found labelling discrepancies in nearly 70% of the extracts tested. WorldWeed sells flowers and resins, not oil.
What CBD oil is
CBD oil combines two distinct elements. On one side, a hemp extract: depending on the process, it keeps a full spectrum of cannabinoids and terpenes (full spectrum), a spectrum with no detectable THC (broad spectrum), or CBD alone, purified to a high concentration (isolate). On the other side, a carrier vegetable oil that dissolves this extract, most often an MCT oil derived from coconut, a hemp oil or an olive oil.
It's this combination - an extract added to a food carrier - that places CBD oil in the category of fortified food products, with the regulatory consequences that follow. An essential oil or cosmetic oil applied to the skin follows a different framework; here, we're talking about a product meant to be swallowed.
Why CBD oil falls under the "novel food" regulation
Regulation (EU) No 2015/2283 governs "novel foods": any ingredient with no history of significant consumption in the European Union before 15 May 1997 must obtain a market authorization before being sold, based on a safety file assessed by the European Food Safety Authority (EFSA). CBD added to a food falls under this framework.
The problem is that EFSA hasn't been able to reach a conclusion. The files submitted by manufacturers lacked sufficient data to establish the safety of regular consumption, particularly regarding the liver, the digestive system, the nervous system and reproduction. As a result, no CBD oil has, to date, obtained novel food authorization in Europe. Without this authorization, the sale remains non-compliant, regardless of the stated quality of the product or the seller's reputation.
What the Ministry of Agriculture's notice says
On 20 May 2026, the Ministry of Agriculture, Food Sovereignty and Forestry published a notice with an unambiguous title: "Food products containing cannabidiol (CBD): illegal products that must be withdrawn from the market." The text states that all food products containing CBD among their ingredients - food supplements included - aren't authorized under the novel food regulation, as EFSA hasn't been able to rule on the safety of CBD.
Two categories remain exempt: hemp seeds and their derivatives, including seed oil (which contains no significant amount of CBD), and hemp leaves intended exclusively for aqueous infusion, provided they aren't enriched with cannabinoids. The notice also announces a rollout of broader controls in 2026, following a rise in reported poisoning cases observed since 2024. It's this strictly enforced framework that explains the disappearance of CBD oils from legal shelves.
CBD oil versus hemp seed oil: don't mix them up
This is the most common confusion. Hemp seed oil is cold-pressed from the plant's seeds, like sunflower or rapeseed oil. It contains no notable amount of CBD - cannabidiol concentrates in the flowers and leaves, not in the seed. It's an ordinary food, rich in omega-3 and omega-6, authorized for sale with no CBD-related restriction.
CBD oil, on the other hand, starts from an extract of flowers or resin, rich in cannabinoids by design, then added to a carrier oil. It's this intentional addition of CBD that triggers the novel food regime. If the label says "hemp oil" with no mention of a CBD level, it's almost certainly the first category, authorized; if a CBD level is shown as a percentage or in mg, it's the second, not authorized as things stand.
What the buyer was risking
Even before the question of legality, CBD oil posed a reliability problem. A study published in JAMA in 2017 by Bonn-Miller and co-authors analyzed 84 CBD-based products bought online in the United States: fewer than 31% showed a CBD content within ±10% of what the label stated. More than 42% of products were under-labelled (more CBD than declared), 26% over-labelled (less CBD than declared). Without an independent lab and a verifiable COA, the buyer had no guarantee of the bottle's actual content.
The May 2026 notice also mentions a rise in reported poisoning cases linked to CBD food products since 2024, with no figures made public at this stage - a point to follow through official publications rather than treat as a settled number.
The only CBD medicine authorized in France
The only CBD-based product to have obtained a market authorization in Europe is Epidyolex, a prescription medicine reserved for rare and severe forms of childhood epilepsy, used under hospital supervision. The quantities used and the medical context bear no relation to an oil bought online for personal use. This medicine status doesn't transfer to any other CBD product, oil included.
If you were looking for CBD oil: what's still freely on sale
CBD flowers and resins remain authorized for sale in France if their Δ9-THC level stays under 0.3%, a framework set by the decree of 30 December 2021 and confirmed for sale by the Council of State's ruling of 29 December 2022. This isn't an equivalent product to an oil: it's inhaled (vaporizing is preferable to burning, since combustion remains harmful to the respiratory tract whatever plant is smoked) rather than swallowed, for a fast, short-lived effect rather than a slow, prolonged one.
The CBD flowers range and the CBD resins range bring together the available products, with CBD levels shown per batch, such as Tyson (19.45%) or Gorilla Hash (48.55%). These formats have their own limits: they're not suited to anyone looking for a discreet, quick intake like a drop under the tongue, and combustion remains inadvisable for respiratory health. Before any purchase, whatever the seller, demand the batch's COA and check the declared THC level - our guide explains how to read a CBD COA step by step. These products aren't recommended for minors, pregnant or breastfeeding women, and medical advice is needed if you're currently on treatment.
Sources
- Ministère de l'Agriculture, de la Souveraineté alimentaire et de la Forêt, notice « Denrées alimentaires contenant du cannabidiol (CBD) : des produits illégaux qui doivent être retirés du marché », 20 May 2026.
- Regulation (EU) No 2015/2283 of the European Parliament and of the Council on novel foods.
- European Food Safety Authority (EFSA), opinion on the novel food status of cannabidiol, 2022.
- Bonn-Miller M.O., Loflin M.J.E., Thomas B.F. et al., « Labeling Accuracy of Cannabidiol Extracts Sold Online », JAMA, 2017.
- Decree of 30 December 2021 implementing Article D. 645-16 of the Public Health Code.
- Council of State ruling of 29 December 2022 (overturning the ban on the sale of CBD flowers and leaves).
- European Medicines Agency (EMA), marketing authorization for Epidyolex (cannabidiol), 2019.
